Clinical trial
Safety,Tolerability and Immunogenicity of Vaccination With VARIVAX in Healthy…
NCT00496327 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00496327 |
|---|---|
| Title | Safety,Tolerability and Immunogenicity of Vaccination With VARIVAX in Healthy Indian Children (V210-056) |
| Official title | Evaluation of Safety,Tolerability and Immunogenicity of Vaccination With VARIVAX (V210)in Healthy Indian Children |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Varicella |
| Intervention type | Biological |
| Interventions | Varicella Virus Vaccine Live (Oka-Merck) |
| Enrollment | 100 |
| Start date | Jun 22, 2005 |
| Primary completion | Oct 6, 2005 |
| Completion | Oct 6, 2005 |
| First posted | Jul 4, 2007 |
| Last update posted | Jan 18, 2019 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: